Ohio's Center for Stem Cell and Regenerative Medicine said last week that it has received $5 million from the state's Third Frontier Commission to help it develop and eventually commercialize stem-cell inventions from its partner institutions.

The CSCRM will use the three-year grant, which was awarded under the Third Frontier's Research and Commercialization Program, to fund nine new research projects this year and at least eight in coming years, a CSCRM official said this week.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.

In Cell this week: dynamics of protein profusion and localization, melanoma classification schemes, and more.

A company says it can generate likenesses of people based on their genetic profiles.

IBM's Watson is learning how to treat leukemia as a fellow at the MD Anderson Cancer Center, according to the Washington Post.

At her blog, Sally Rockey dives into National Institutes of Health funding data.